
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lactobacillus bulgaricus LB-51 is a probiotic strain that produces lactic acid and bacteriocins to inhibit pathogenic bacteria in the gut. It colonizes the intestinal tract and modulates immune responses through interaction with intestinal epithelial cells.

Reported Benefits (Provisional)
Origin & History

Lactobacillus bulgaricus LB-51 is a probiotic strain traditionally used in yogurt production. It is known for its role in enhancing digestive health and supporting the immune system.
Research Narrative (Provisional)
Studies show Lactobacillus bulgaricus LB-51 can improve gut health and support the immune system. Research also indicates its potential in aiding lactose digestion.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in probiotics. - Supports digestive and immune health. - Enhances lactose digestion.
Reported Mechanism (Provisional)
Lactobacillus bulgaricus LB-51 produces lactic acid and acetic acid, lowering intestinal pH to create an inhospitable environment for pathogenic bacteria. The strain synthesizes bacteriocins, antimicrobial peptides that directly target harmful microorganisms. It adheres to intestinal epithelial cells and stimulates the production of secretory IgA antibodies through activation of Peyer's patches in the gut-associated lymphoid tissue.
Clinical Narrative (Provisional)
Human studies on Lactobacillus bulgaricus LB-51 are limited, with most research conducted on the broader L. bulgaricus species. Small-scale trials with 20-40 participants have shown improvements in digestive symptoms and increased beneficial bacterial counts within 2-4 weeks of supplementation. The 30% increase in beneficial bacteria cited requires verification through larger randomized controlled trials. More robust clinical evidence is needed to confirm strain-specific therapeutic effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







